Ticker

Analyst Price Targets — VBLT

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
April 28, 2022 6:46 amChardan Capital$5.00$1.57Benzinga Chardan Capital Initiates Coverage On Vascular Biogenics with Buy Rating, Announces Price Target of $5

No recent news available for VBLT.

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for VBLT.

No House trades found for VBLT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top